Across North America, increasing investment in microbiome research and precision healthcare is accelerating the development of microbiome-based drugs and diagnostic solutions. Researchers are examining the role of microbial communities in chronic diseases, immune responses, gastrointestinal disorders, metabolism, and other health conditions, supported by advances in sequencing and data...